Anlotinib Impurity 1 | CAS 2205042-80-2 - Request Quote
Anlotinib Impurity 1
| SZ CAT No: | SZ-A201002 |
| CAS No | 2205042-80-2 |
| Mol.F. | C30H28FN3O3 |
| Mol.Wt. | 497.6 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Anlotinib Impurity 1 is chemically 1-(((4-((3-Benzyl-4-fluoro-2-methyl-1H-indol-5-yl)oxy)-6-methoxyquinolin-7-yl)oxy)methyl)cyclopropan-1-amine. Anlotinib Impurity 1 is supplied with detailed characterization data compliant with regulatory guideline. Anlotinib Impurity 1 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Anlotinib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 2205042-80-2
Purchase 2205042-80-2
Order 2205042-80-2
Enquire 2205042-80-2
price of 2205042-80-2
2205042-80-2 Supplier
2205042-80-2 Manufacturer
2205042-80-2 Exporter
buy high quality Anlotinib Impurity 1
Purchase Anlotinib Impurity 1
Anlotinib Impurity 1 suppliers
Anlotinib Impurity 1 manufacturers
Anlotinib Impurity 1 price
Order Anlotinib Impurity 1
Enquire Anlotinib Impurity 1
Anlotinib Impurity 1 cost
Anlotinib Impurity 1 Supplier
Anlotinib Impurity 1 Distributor
Anlotinib Impurity 1 for Method Validation
Anlotinib Reference Standard
Anlotinib Impurity 1 for ANDA Filing
Anlotinib Impurity 1 for Forced Degradation Studies
Anlotinib Impurity 1 Identification Standards
Anlotinib Impurity 1 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.